Press Releases Stay abreast of the news from Bluestar Genomics. November 5, 2021 Bluestar Genomics Presents New Data Showing Its Liquid Biopsy Test Detects Pancreatic Cancer Signal May 12, 2021 Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board March 31, 2021 Bluestar Genomics Receives FDA Breakthrough Device Designation for First-of-Its-Kind Pancreatic Cancer Screening Test January 29, 2020 Bluestar Genomics’ Breakthrough Study Highlights Promising Data for Multi-Cancer Detection From a Single Blood Draw September 24, 2019 Bluestar Genomics to Share New Noninvasive Data for Earlier Cancer Detection at 11th CNAPs International Symposium September 10, 2019 Bluestar Genomics Presents New Data Demonstrating Feasibility of a Novel Blood Test for Earlier Detection and Classification of Multiple Cancers <<123>> Epigenomics-based Tests for Early Cancer Detection Learn About Our Tests
